The weekly litigation news digest is live. Subscribe now

IP Verse

Name NOT Displayed FOR Gdpr Reasons Represented BY Oswin Ridderbusch vs. Amgen - APP_546231/2023

The case APP_546231/2023 was filed by the plaintiff Name NOT Displayed FOR Gdpr Reasons Represented BY Oswin Ridderbusch, Redacted Natural Person Name against the defendant Amgen, Sanofi Aventis Deutschland on 11 Jul, 2023.

Case Timeline

11 Jul, 2023
Case Filed
14 Jul, 2023
Interim Conference
Today Dec 31, 2025
Oral Procedure
Decision

Case Details

    Case Number:

    APP_546231/2023

    Patent Number:

    EP3666797

    Filing Date:

    11 Jul, 2023

    Proceeding Type:

    Generic

    Case Phase:

    Written Phase

    Plaintiffs:

    • Name NOT Displayed FOR Gdpr Reasons Represented BY Oswin Ridderbusch
    • Redacted Natural Person Name

    Plaintiff Representative:

    • Oswin RIDDERBUSCH

    Defendants:

    • Amgen
    • Sanofi Aventis Deutschland
    • Sanofi Aventis Groupe
    • Sanofi Winthrop Industrie

    Defendant Representative:

    • Daniel Wise
    • Koen Bijvank

    Judges:

    • Andras Kupecz
    • Casper Struve
    • Ulrike Voß

    Court Division:

    First Instance, Central Division - Munich

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Dec 25, 2025
DateTitle

Notify me when new UPC document is filed

Sep 20, 2023Outcome Of The Order
Sep 20, 2023Order Rejecting Rule 262.1(B) Application DATED 20 September
Aug 30, 2023.08.30 Act459505 Sanofi No Comments On File Inspection Request (Signed)
Aug 28, 2023Preliminary Order 262(1)(B) DATED 28 August
Aug 18, 2023Comments In Response To The Preliminary Order Of August 4, Submitted Under Rule 264 Rop
Aug 4, 2023Preliminary Order 262(1)(B) DATED 4 August
Jul 28, 2023Defendant'S Comments Pursuant To R. 264 Rop
Jul 28, 2023Claimants' Reply To File Inspection Request
Jul 14, 2023Preliminary Order 262(1)(B) DATED 14 July
Jul 10, 2023Application For File Inspection

More cases involving EP3666797B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Dec 25, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_3214/2025Jan 21, 2025Name NOT Displayed FOR Gdpr Reasons Represented BY Sture Rygaard, Redacted Natural Person NameAmgen, Dehns, Name NOT Displayed FOR Gdpr Reasons Represented BY Oswin Ridderbusch, Redacted Natural Person Name, Sanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51679/2024Sep 13, 2024AmgenSanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51683/2024Sep 13, 2024AmgenRegeneron Pharmaceuticals

More cases involving Name NOT Displayed FOR Gdpr Reasons Represented BY Oswin Ridderbusch

No cases found - set alert to stay updated on new cases

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Dec 25, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -